PharmaEssentia Statistics
Total Valuation
PharmaEssentia has a market cap or net worth of EUR 4.96 billion. The enterprise value is 4.40 billion.
Market Cap | 4.96B |
Enterprise Value | 4.40B |
Important Dates
The next estimated earnings date is Monday, May 12, 2025.
Earnings Date | May 12, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +3.59% |
Shares Change (QoQ) | +2.05% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 256.37M |
Valuation Ratios
The trailing PE ratio is 56.78.
PE Ratio | 56.78 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 6.19 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 76.42, with an EV/FCF ratio of 88.68.
EV / Earnings | 50.39 |
EV / Sales | 16.27 |
EV / EBITDA | 76.42 |
EV / EBIT | 91.25 |
EV / FCF | 88.68 |
Financial Position
The company has a current ratio of 9.94, with a Debt / Equity ratio of 0.04.
Current Ratio | 9.94 |
Quick Ratio | 9.34 |
Debt / Equity | 0.04 |
Debt / EBITDA | 0.47 |
Debt / FCF | 0.57 |
Interest Coverage | 78.23 |
Financial Efficiency
Return on equity (ROE) is 11.54% and return on invested capital (ROIC) is 4.05%.
Return on Equity (ROE) | 11.54% |
Return on Assets (ROA) | 3.72% |
Return on Invested Capital (ROIC) | 4.05% |
Return on Capital Employed (ROCE) | 6.09% |
Revenue Per Employee | 2.19M |
Profits Per Employee | 667,038 |
Employee Count | 131 |
Asset Turnover | 0.33 |
Inventory Turnover | 0.86 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +66.90% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +66.90% |
50-Day Moving Average | 19.40 |
200-Day Moving Average | 19.05 |
Relative Strength Index (RSI) | 33.86 |
Average Volume (20 Days) | n/a |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PharmaEssentia had revenue of EUR 286.85 million and earned 87.38 million in profits. Earnings per share was 0.26.
Revenue | 286.85M |
Gross Profit | 252.16M |
Operating Income | 51.16M |
Pretax Income | 88.24M |
Net Income | 87.38M |
EBITDA | 54.41M |
EBIT | 51.16M |
Earnings Per Share (EPS) | 0.26 |
Balance Sheet
The company has 620.29 million in cash and 28.45 million in debt, giving a net cash position of 591.85 million.
Cash & Cash Equivalents | 620.29M |
Total Debt | 28.45M |
Net Cash | 591.85M |
Net Cash Per Share | n/a |
Equity (Book Value) | 809.40M |
Book Value Per Share | 2.43 |
Working Capital | 673.60M |
Cash Flow
In the last 12 months, operating cash flow was 75.05 million and capital expenditures -25.40 million, giving a free cash flow of 49.65 million.
Operating Cash Flow | 75.05M |
Capital Expenditures | -25.40M |
Free Cash Flow | 49.65M |
FCF Per Share | n/a |
Margins
Gross margin is 87.91%, with operating and profit margins of 17.83% and 30.46%.
Gross Margin | 87.91% |
Operating Margin | 17.83% |
Pretax Margin | 30.76% |
Profit Margin | 30.46% |
EBITDA Margin | 18.97% |
EBIT Margin | 17.83% |
FCF Margin | 17.31% |
Dividends & Yields
PharmaEssentia does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.59% |
Shareholder Yield | -3.59% |
Earnings Yield | 1.76% |
FCF Yield | 1.00% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
PharmaEssentia has an Altman Z-Score of 29.21.
Altman Z-Score | 29.21 |
Piotroski F-Score | n/a |